Skip to main content
Fig. 6 | Stem Cell Research & Therapy

Fig. 6

From: Mesenchymal stromal cell therapy for COVID-19-induced ARDS patients: a successful phase 1, control-placebo group, clinical trial

Fig. 6

A Serum IL-6 levels in the control and intervention groups during the study. B Serum IFN-g levels in the control and intervention groups during the study. C Serum TNF-α levels in the control and intervention groups during the study. D Serum IL-1β levels in the control and intervention groups during the study. E Serum IL-17A levels in the control and intervention groups during the study. F Serum TGF-β levels in the control and intervention groups during the study. G Serum IL-10 levels in the control and intervention groups during the study. All measurements were performed by ELISA method

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512